Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China flag China · Delayed Price · Currency is CNY
3.490
+0.030 (0.87%)
Feb 3, 2026, 3:00 PM CST

SHA:600664 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2,7413,6343,0602,4331,592897
Cash & Short-Term Investments
2,7413,6343,0602,4331,592897
Cash Growth
-12.32%18.75%25.76%52.85%77.49%32.79%
Accounts Receivable
5,2234,9854,9614,8184,7494,703
Other Receivables
128.76130.8146.47178.5185.8634.19
Receivables
5,3525,1165,1074,9974,8354,737
Inventory
2,0811,8911,9241,8042,0641,862
Prepaid Expenses
-9.6710.74.93--
Other Current Assets
340.47327.8293.61320.05242.45312
Total Current Assets
10,51410,97910,3969,5608,7337,808
Property, Plant & Equipment
2,3052,3852,4682,6412,8352,783
Long-Term Investments
33.4933.4938.4237.6239.3248.72
Goodwill
39.1639.1639.1539.1539.15-
Other Intangible Assets
389.55408.4451.14444.21480.78494.1
Long-Term Deferred Tax Assets
608.93603.74597.85600.19599.44602.86
Long-Term Deferred Charges
83.763.441.2963.9671.7664.58
Other Long-Term Assets
107.42104.2480.1648.8444.1146.14
Total Assets
14,08114,61614,11213,43512,84211,848
Accounts Payable
3,9304,0393,9513,5103,4823,668
Accrued Expenses
523.46618.37597.07668.02628.3656.59
Short-Term Debt
1,0471,5541,6581,9332,0781,634
Current Portion of Long-Term Debt
139.79104.76104.04103.64102.92102.93
Current Portion of Leases
-36.2331.2135.9336.74-
Current Income Taxes Payable
110.8657.2180.198.2985.1760.49
Current Unearned Revenue
100.58311.61282.45235.87119.7398.33
Other Current Liabilities
1,4241,3831,5391,4171,3221,087
Total Current Liabilities
7,2768,1058,2438,0027,8557,307
Long-Term Debt
31.9331.732.6333.1934.0936.7
Long-Term Leases
27.4335.3231.0843.6861.61-
Long-Term Unearned Revenue
283.17300.74319.07333.61375.1407.82
Long-Term Deferred Tax Liabilities
6.585.736.916.291.681.61
Other Long-Term Liabilities
47.9847.9856.6469.794.7106.05
Total Liabilities
7,6738,5268,6898,4888,4227,859
Common Stock
2,5192,5192,5212,5262,5182,507
Additional Paid-In Capital
663.33684.11685.32688.6675.43662.57
Retained Earnings
4,2393,9113,2822,8872,4262,054
Treasury Stock
---3.98-13.01-15.53-
Comprehensive Income & Other
-1,763-1,763-1,760-1,760-1,757-1,744
Total Common Equity
5,6585,3504,7244,3283,8473,480
Minority Interest
749.92739.49698.75618.87573.25508.92
Shareholders' Equity
6,4086,0895,4234,9474,4203,989
Total Liabilities & Equity
14,08114,61614,11213,43512,84211,848
Total Debt
1,2461,7621,8572,1492,3131,774
Net Cash (Debt)
1,4951,8721,203284.1-720.94-876.71
Net Cash Growth
14.45%55.56%323.57%---
Net Cash Per Share
0.600.740.490.11-0.29-0.35
Filing Date Shares Outstanding
2,5192,5192,5212,5262,5182,507
Total Common Shares Outstanding
2,5192,5192,5212,5262,5182,507
Working Capital
3,2382,8742,1531,558878.23501.08
Book Value Per Share
2.252.121.871.711.531.39
Tangible Book Value
5,2294,9024,2343,8443,3272,986
Tangible Book Value Per Share
2.081.951.681.521.321.19
Buildings
-4,6594,6444,7024,6834,605
Machinery
-3,3083,2143,1693,5453,743
Construction In Progress
-74.7369.1266.22164.92159.79
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.